Valneva's inactivated covid-19 vaccine candidate shown to neutralize omicron variant

Saint herblain (france), january 19 , 2022 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced results from an initial laboratory study demonstrating that serum antibodies induced by three doses of valneva's inactivated covid-19 vaccine candidate, vla2001, neutralize the omicron variant.
VALN Ratings Summary
VALN Quant Ranking